These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 22449455)

  • 1. Enhancing crystalline properties of a cardiovascular active pharmaceutical ingredient using a process analytical technology based crystallization feedback control strategy.
    Saleemi AN; Steele G; Pedge NI; Freeman A; Nagy ZK
    Int J Pharm; 2012 Jul; 430(1-2):56-64. PubMed ID: 22449455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spherical crystallization of drugs.
    Kovačič B; Vrečer F; Planinšek O
    Acta Pharm; 2012 Mar; 62(1):1-14. PubMed ID: 22472445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of feedback control and in situ milling to improve particle size and shape in the crystallization of a slow growing needle-like active pharmaceutical ingredient.
    Yang Y; Pal K; Koswara A; Sun Q; Zhang Y; Quon J; McKeown R; Goss C; Nagy ZK
    Int J Pharm; 2017 Nov; 533(1):49-61. PubMed ID: 28935256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of spherical iron(II) sulfate heptahydrate-containing solid particles with sustained drug release.
    Szabó-Révész P; Farkas B; Gregor T; Nagy K; Pallagi E
    Eur J Pharm Biopharm; 2007 May; 66(2):193-9. PubMed ID: 17125982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facilitating the use of counter-current chromatography in pharmaceutical purification through use of organic solvent nanofiltration.
    Rundquist E; Pink C; Vilminot E; Livingston A
    J Chromatogr A; 2012 Mar; 1229():156-63. PubMed ID: 22326182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring of antisolvent crystallization of sodium scutellarein by combined FBRM-PVM-NIR.
    Liu X; Sun D; Wang F; Wu Y; Chen Y; Wang L
    J Pharm Sci; 2011 Jun; 100(6):2452-9. PubMed ID: 21246557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applications of process analytical technology to crystallization processes.
    Yu LX; Lionberger RA; Raw AS; D'Costa R; Wu H; Hussain AS
    Adv Drug Deliv Rev; 2004 Feb; 56(3):349-69. PubMed ID: 14962586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applications of NIR spectroscopy to monitoring and analyzing the solid state during industrial crystallization processes.
    Févotte G; Calas J; Puel F; Hoff C
    Int J Pharm; 2004 Apr; 273(1-2):159-69. PubMed ID: 15010140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of salmeterol xinafoate microparticle production by conventional and novel antisolvent crystallization.
    Murnane D; Marriott C; Martin GP
    Eur J Pharm Biopharm; 2008 May; 69(1):94-105. PubMed ID: 17981448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of niflumic acid prepared by rapid microwave-assisted evaporation.
    Radacsi N; Stefanidis GD; Szabó-Révész P; Ambrus R
    J Pharm Biomed Anal; 2014 Sep; 98():16-21. PubMed ID: 24873734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of direct crystallization for racemic compound propranolol hydrochloride.
    Wang X; Lu J; Ching CB
    J Pharm Sci; 2007 Oct; 96(10):2735-45. PubMed ID: 17549769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation of tablets containing an 'in-process' amorphized active pharmaceutical ingredient.
    Jójárt-Laczkovich O; Szabó-Révész P
    Drug Dev Ind Pharm; 2011 Nov; 37(11):1272-81. PubMed ID: 21457129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developing an environmentally benign process for the production of microparticles: amphiphilic crystallization.
    Murnane D; Marriott C; Martin GP
    Eur J Pharm Biopharm; 2008 May; 69(1):72-82. PubMed ID: 18082385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation of indomethacin-saccharin cocrystals using supercritical fluid technology.
    Padrela L; Rodrigues MA; Velaga SP; Matos HA; de Azevedo EG
    Eur J Pharm Sci; 2009 Aug; 38(1):9-17. PubMed ID: 19477273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applications of NIR in early stage formulation development. Part I. Semi-quantitative blend uniformity and content uniformity analyses by reflectance NIR without calibration models.
    Li W; Bashai-Woldu A; Ballard J; Johnson M; Agresta M; Rasmussen H; Hu S; Cunningham J; Winstead D
    Int J Pharm; 2007 Aug; 340(1-2):97-103. PubMed ID: 17467204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organic solvents in the pharmaceutical industry.
    Grodowska K; Parczewski A
    Acta Pol Pharm; 2010; 67(1):3-12. PubMed ID: 20210074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of FT-NIR for API content assay in organic solvent media: a single calibration for multiple downstream processing streams.
    Rodrigues LO; Cardoso JP; Menezes JC
    Talanta; 2008 Jun; 75(5):1203-7. PubMed ID: 18585202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Wet Milling Combined with Temperature Cycling to Minimize Crystal Agglomeration in a Sequential Antisolvent-Cooling Crystallization.
    Sun Z; Quon JL; Papageorgiou CD; Benyahia B; Rielly CD
    Cryst Growth Des; 2022 Aug; 22(8):4730-4744. PubMed ID: 35942120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal engineering of the composition of pharmaceutical phases. Do pharmaceutical co-crystals represent a new path to improved medicines?
    Almarsson O; Zaworotko MJ
    Chem Commun (Camb); 2004 Sep; (17):1889-96. PubMed ID: 15340589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of precipitation methods for the production of water-insoluble drug nanocrystals: production techniques and stability of nanocrystals.
    Xia D; Gan Y; Cui F
    Curr Pharm Des; 2014; 20(3):408-35. PubMed ID: 23651396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.